期刊文献+

Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma 被引量:39

Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma
下载PDF
导出
摘要 AIM:To understand the clinicopathological characteristics and treatment selections and improve survival and provide valuable information for patients with intrahepatic cholangiocarcinoma(ICC). METHODS:We retrospectively evaluated 5311 liver cancer patients who received resection between October 1999 and December 2003.Of these,429(8.1%)patients were diagnosed with ICC,and their clinicopathological, surgical,and survival characteristics were analyzed. RESULTS:Upper abdominal discomfort or pain(65.0%), no symptoms(12.1%),and hypodynamia(8.2%)were the major causes for medical attention.Laboratory tests showed 198(46.4%)patients were HBsAg positive, 90(21.3%)hadα-fetoprotein>20μg/L,50(11.9%) carcinoembryonic antigen>10μg/L,and 242(57.5%) carbohydrate antigen 19-9(CA19-9)>37 U/mL.Survival data was available for 329(76.7%)patients and their mean survival time was 12.4 mo.The overall survival of the patients with R0,R1 resection and punching exploration were 18.3,6.6 and 5.6 mo,respectively. Additionally,CA19-9>37 U/mL was associated with lymph node metastases,but inversely associated withcirrhosis.Multivariate analysis indicated that radical resection,lymph node metastases,macroscopic tumor thrombi and size,and CA19-9 were associated with prognosis. CONCLUSION:Surgical radical resection is still the most effective means to cure ICC.Certain laboratory tests(such as CA19-9)can effectively predict the survival of the patients with ICC. AIM:To understand the clinicopathological characteristics and treatment selections and improve survival and provide valuable information for patients with intrahepatic cholangiocarcinoma(ICC). METHODS:We retrospectively evaluated 5311 liver cancer patients who received resection between October 1999 and December 2003.Of these,429(8.1%)patients were diagnosed with ICC,and their clinicopathological, surgical,and survival characteristics were analyzed. RESULTS:Upper abdominal discomfort or pain(65.0%), no symptoms(12.1%),and hypodynamia(8.2%)were the major causes for medical attention.Laboratory tests showed 198(46.4%)patients were HBsAg positive, 90(21.3%)hadα-fetoprotein〉20μg/L,50(11.9%) carcinoembryonic antigen〉10μg/L,and 242(57.5%) carbohydrate antigen 19-9(CA19-9)〉37 U/mL.Survival data was available for 329(76.7%)patients and their mean survival time was 12.4 mo.The overall survival of the patients with R0,R1 resection and punching exploration were 18.3,6.6 and 5.6 mo,respectively. Additionally,CA19-9〉37 U/mL was associated with lymph node metastases,but inversely associated withcirrhosis.Multivariate analysis indicated that radical resection,lymph node metastases,macroscopic tumor thrombi and size,and CA19-9 were associated with prognosis. CONCLUSION:Surgical radical resection is still the most effective means to cure ICC.Certain laboratory tests(such as CA19-9)can effectively predict the survival of the patients with ICC.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第47期5976-5982,共7页 世界胃肠病学杂志(英文版)
基金 Supported by The Shanghai Natural Science Foundation,No.09ZR1401100
关键词 临床病理 肝癌 胆管 预后 平均存活时间 癌胚抗原 HBSAG 临床特点 Intrahepatic cholangiocarcinoma Diagnosis Pathology Surgery Survival
  • 相关文献

参考文献2

二级参考文献16

  • 1Chao Xu Zheng~1 Wen Hua Zhan~1 Ji Zong Zhao~2 Dong Zheng~3 Dong Ping Wang~1 Yu Long He~1 Zhang Qing Zheng~1 ~1Department of General Surgery,~2Laboratory of Surgery,~3Department of Medicine,First Affiliated Hospital,Sun Yat-Sen University of Medical Sciences,Guangzhou 510080,Guangdong Province,ChinaDr.Chao Xu Zheng now working as a surgeon and lecturer in the Department of General Surgery,First Affiliated Hospital,Sun Yat-Sen University of Medical Sciences,who is a Ph.D.student,having 7 papers published..The prognostic value of preoperative serum levels of CEA,CA19-9 and CA72-4 in patients with colorectal cancer[J].World Journal of Gastroenterology,2001,7(3):431-434. 被引量:25
  • 2Francesco Donato,Umberto Gelatti,Alessandro Tagger,Maurizio Favret,Maria Lisa Ribero,Francesco Callea,Claudia Martelli,Antonella Savio,Paola Trevisi,Giuseppe Nardi.Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy[J].Cancer Causes and Control.2001(10)
  • 3Tomonori Shimonishi,Motoko Sasaki,Yasuni Nakanuma.Precancerous lesions of intrahepatic cholangiocarcinoma[J].Journal of Hepato - Biliary - Pancreatic Surgery.2000(6)
  • 4Tadashi Terada,Yasuni Nakanuma.Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths[J].Virchows Archiv A Pathological Anatomy and Histopathology.1992(4)
  • 5Khan SA,Thomas HC,Davidson BR,Taylor-Robinson SD.Cholangiocarcinoma[].Lancet.2005
  • 6Shin HR,Lee CU,Park HJ,Seol SY,Chung JM,Choi HC,Ahn YO,Shigemastu T.Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea[].Int J Epidemiol.1996
  • 7Parkin DM,Srivatanakul P,Khlat M,Chenvidhya D,Chotiwan P,Insiripong S,L’Abbe KA,Wild CP.Liver cancer in Thailand. A case-control study of cholangiocarcinoma[].Int J Cancer.1991
  • 8Broome U,Lofberg R,Veress B,Eriksson LS.Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential[].Hepatology.1995
  • 9Chen MF.Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment[].J Gastroenterol Hepatol.1999
  • 10Su CH,Shyr YM,Lui WY,P’Eng FK.Hepatolithiasis associated with cholangiocarcinoma[].Br J Surg.1997

共引文献89

同被引文献179

引证文献39

二级引证文献233

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部